SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001362310-08-003276
Filing Date
2008-06-18
Accepted
2008-06-18 08:42:58
Documents
3
Period of Report
2008-06-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c73671e8vk.htm 8-K 14285
2 EXHIBIT 99.1 c73671exv99w1.htm EX-99.1 9456
3 GRAPHIC c73671p7367101.jpg GRAPHIC 8089
  Complete submission text file 0001362310-08-003276.txt   36623
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 08904655
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1